Neuromuscular electrical stimulation
Intervention3 papers3 findings
A partially randomised human trial with marked baseline imbalance reports reduced dual-task gait cost with neuromuscular electrical stimulation added to usual rehabilitation over three weeks in the Time × Group analysis, but no effect in the unadjusted post-intervention comparison.
- Human trial1
Outcomes
2Dual-task gait cost
no changein humans1downin humans1Very low certainty
1 study
Dual-task gait cost
no changein humans1downin humans1Very low certainty
Neuromuscular electrical stimulation has no effect on dual-task gait cost in humans.
Human trialUnadjusted post-intervention comparison of adjunctive NMES versus usual rehabilitation carethree weeksn = 19
Adjunctive neuromuscular electrical stimulation and cognitive-motor interference during gait in older inpatients · Experimental gerontology · 5 Oct 2026
Neuromuscular electrical stimulation decreases dual-task gait cost in humans (Time × Group β = 20.68 percentage points, 95% CI [7.92, 33.44]).
Human trialAdjunctive to usual rehabilitation care; partially randomized allocation with marked baseline imbalance; Time × Group interactionthree weeksn = 19
Adjunctive neuromuscular electrical stimulation and cognitive-motor interference during gait in older inpatients · Experimental gerontology · 5 Oct 2026
Muscle mass
upin humans1High certainty
1 study
Muscle mass
upin humans1High certainty
Neuromuscular electrical stimulation improves muscle mass in humans (SMD = 0.66, 95% CI = 0.30-1.02).
Reviewin adults with sarcopenia or secondary muscle lossskeletal musclen = 676
Efficacy of Neuromuscular Electrical Stimulation in Mitigating Muscle Mass Loss: A Systematic Review and Meta-Analysis of Randomized Controlled Trials · Muscle & nerve · 4 Sep 2026
Funding
Veterans Affairs1 grant since 2022